E-selection, endothelial selectin
72 Yan et al
Tirzepatide and semaglutide are appropriate for patients who: Have at least 20 pounds of fat to lose Struggle with cravings, overeating, or stalled progress despite trying on their own Have signs of insulin resistance, metabolic syndrome, or hormone-related weight gain Want a physician-led, sustainable plan that protects metabolism, muscle, and appearance Who Should Not Use Tirzepatide (Zepbound) or Semaglutide (Wegovy)
The peptide remains stable at room temperature for up to 30 days, making travel convenient
Risks and Considerations for Endurance Athletes Using GLP-1 RAs If a triathlete or endurance athlete is on (or planning to take) a GLP-1 receptor agonist medication, there are several key considerations and potential risks to keep in mind
Semaglutide can cause nausea, vomiting, and reduced food intake, which may affect vitamin K absorptiona factor that influences warfarin effectiveness